Cogent Biosciences (COGT) Other Operating Expenses (2020)

Cogent Biosciences (COGT) recorded quarterly Other Operating Expenses of $46.9 million in Q3 2020.

Cogent Biosciences (COGT) Other Operating Expenses (2020) Analysis & Trends

Cogent Biosciences' Other Operating Expenses history runs 1 years deep, the most recent figure standing at $46.9 million for Q3 2020.

In Q3 2020, Other Operating Expenses changed N/A year-over-year to $46.9 million; the TTM figure through Jun 2021 stood at $46.9 million (changed N/A YoY), while the FY2020 annual figure was $46.9 million, changed N/A from the prior year.
Other Operating Expenses was $46.9 million for Q3 2020 at Cogent Biosciences.
In the past five years, Other Operating Expenses ranged from a high of $46.9 million in Q3 2020 to a low of $46.9 million in Q3 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn
9	Abivax	95.45 Bn	95.45 Bn	-
10	Cogent Biosciences	5.19 Bn	4.32 Bn	-

Historic Data

Download Data

Date	Value
Sep 30, 2020	46.91 Mn